Literature DB >> 7362816

Self-medication with pilocarpine among outpatients in a glaucoma clinic.

S E Norell, P A Granström.   

Abstract

A recording medication monitor and fluorescein technique were used to study self-medication by 82 patients with primary open-angle glaucoma for whom pilocarpine eye drops 3 times a day had been prescribed. Of these patients 34 (41%) missed 6 or more doses during a 20-day period, and for 35 (43%) an 8-hour dose interval was exceeded at least 20% of the time. Consequences may include lack of effectiveness in preventing visual loss and unnecessary prescription of more potent, and more toxic, drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362816      PMCID: PMC1039365          DOI: 10.1136/bjo.64.2.137

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  A comparison of patient compliance in treated vs untreated ocular hypertension.

Authors:  J F Bigger
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1976 Mar-Apr

2.  Medication monitor for ophthalmology.

Authors:  R D Yee; P M Hahn; R E Christensen
Journal:  Am J Ophthalmol       Date:  1974-11       Impact factor: 5.258

3.  Patients' viewpoint of glaucoma therapy.

Authors:  P A Vincent
Journal:  Sight Sav Rev       Date:  1972

4.  Visual loss in a glaucoma clinic. I. Sociological considerations.

Authors:  G L Spaeth
Journal:  Invest Ophthalmol       Date:  1970-01

5.  The inaccuracy in using interviews to estimate patient reliability in taking medications at home.

Authors:  L Gordis; M Markowitz; A M Lilienfeld
Journal:  Med Care       Date:  1969 Jan-Feb       Impact factor: 2.983

6.  Intraocular pressure control with twice-daily pilocarpine in two vehicle solutions.

Authors:  H A Quigley; I P Pollack
Journal:  Ann Ophthalmol       Date:  1977-04

7.  Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

Authors:  D L Sackett; R B Haynes; E S Gibson; B C Hackett; D W Taylor; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

8.  Doctor-patient relationship in glaucoma therapy.

Authors:  R S Riffenburgh
Journal:  Arch Ophthalmol       Date:  1966-02

9.  Evaluation of recall system for glaucoma suspects and patients.

Authors:  J Rosenthal
Journal:  Sight Sav Rev       Date:  1967

10.  Pilocarpine and intraocular pressure. Duration of effectiveness of 4 percent and 8 percent pilocarpine instillation.

Authors:  S M Drance; M Bensted; M Schulzer
Journal:  Arch Ophthalmol       Date:  1974-02
View more
  14 in total

Review 1.  Compliance aids--do they work?

Authors:  P H Rivers
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

2.  Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

3.  A study of the causes of non-compliance by patients prescribed eyedrops.

Authors:  A J Winfield; D Jessiman; A Williams; L Esakowitz
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

4.  Long-term treatment with Pilogel/beta-blocker in glaucoma patients.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Int Ophthalmol       Date:  1991-07       Impact factor: 2.031

5.  Compliance with treatment of patients with chronic open-angle glaucoma.

Authors:  J M MacKean; A R Elkington
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

6.  A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure.

Authors:  E Stenkula; K Wettrell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

7.  Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects.

Authors:  P A Granström
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

8.  The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.

Authors:  Betsy Sleath; Susan Blalock; David Covert; Jennifer L Stone; Asheley Cockrell Skinner; Kelly Muir; Alan L Robin
Journal:  Ophthalmology       Date:  2011-12       Impact factor: 12.079

9.  First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results.

Authors:  Jordana K Schmier; David W Covert
Journal:  Clin Ophthalmol       Date:  2010-05-14

10.  First-year treatment costs among new initiators of topical prostaglandin analogs.

Authors:  Jordana K Schmier; David W Covert; Alan L Robin
Journal:  Clin Ophthalmol       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.